A rare genetic mutation in a European sperm donor has reportedly caused cancer in 10 children, highlighting the need for ...

After a man’s sperm was used to conceive at least 67 children across 46 families, it was discovered that he had a rare ...

Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains ...

Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast ...

For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often ...

The increased genetic complexity and similarity to adult cancers’ genetic diversity could also present new therapeutic opportunities.

Sperm from a single donor in Europe has reportedly been used to conceive at least 67 pregnancies, although the donor carried a rare cancer-causing mutation. The donor’s mutation has been linked ...

Vepdegestrant significantly improved outcomes for certain patients with ER-positive, HER2-negative advanced breast cancer ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...